Checkpoint Therapeutics inc (CKPT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CKPT Annual Balance Sheets →
Examining balance sheet movements between Checkpoint Therapeutics inc and Mar 31 2024 reveals how Mar 31 2025 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent33.04
Cash & Short-term Investments33.00
Other Receivables, Net, Current0.00
Prepaid Expense And Other Assets Current1.12
Total Current Assets34.16
Total Assets34.16
Liabilities
Accounts Payable and Accrued Liabilities, Current LI14.74
Other Liabilities, Current3.13
Total Current Liabilities17.87
Total Long-term Debt0.00
Common Stock Warrant Liabilities Current0.26
Total Liabilities17.87
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock398.07
Retained Earnings / Accumulated Deficit-381.79
Other Equity0.00
Common Stockholder's Equity16.30
Total Stockholder's Equity16.30
Liabilities & Stockholder's Equity34.16
4 historic quarters locked

Sign in to unlock the full Checkpoint Therapeutics inc balance sheet history.

About Checkpoint Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001410578-25-001233

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.